Pictet Asset Management Holding SA Sells 1,049 Shares of DaVita Inc. (NYSE:DVA)

Pictet Asset Management Holding SA cut its stake in DaVita Inc. (NYSE:DVA) by 3.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,838 shares of the company’s stock after selling 1,049 shares during the period. Pictet Asset Management Holding SA’s holdings in DaVita were worth $4,163,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Franklin Resources Inc. lifted its stake in shares of DaVita by 134.6% in the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after buying an additional 31,502 shares during the period. FMR LLC raised its holdings in DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of DaVita by 201.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after acquiring an additional 49,885 shares during the period. Neo Ivy Capital Management acquired a new stake in shares of DaVita during the 3rd quarter worth approximately $726,000. Finally, Hussman Strategic Advisors Inc. increased its position in shares of DaVita by 200.0% during the fourth quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company’s stock valued at $3,769,000 after purchasing an additional 16,800 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DVA has been the topic of a number of recent research reports. Barclays boosted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Cowen reissued a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. StockNews.com cut shares of DaVita from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $166.33.

DaVita Price Performance

Shares of DaVita stock opened at $149.37 on Friday. The stock has a market capitalization of $11.95 billion, a price-to-earnings ratio of 13.91, a P/E/G ratio of 1.07 and a beta of 1.04. The firm’s 50-day moving average price is $155.75 and its two-hundred day moving average price is $157.28. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.